USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

Sona Frankova,1 Milan Jirsa,2 Dusan Merta,3 Magdalena Neroldova,2 Petr Urbanek,4 Renata Senkerikova,1 Julius Spicak,1 Jan Sperl1 1Department of Hepatogastroenterology, 2Laboratory of Experimental Hepatology, 3Department of Anesthesiology, Resuscitation and Intensive Care, Institute for Clinical and...

Full description

Bibliographic Details
Main Authors: Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
chronic hepatitis C
interferon sensitive gene
USP18
protease inhibitor
virological response
Online Access:https://www.dovepress.com/usp18-downregulation-in-peripheral-blood-mononuclear-cells-predicts-no-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/usp18-downregulation-in-peripheral-blood-mononuclear-cells-predicts-no-peer-reviewed-article-TCRM

Similar Items